查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
結核診斷的全球市場 - 成長，未來預測，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1192924

結核診斷的全球市場 - 成長，未來預測，競爭分析(2022年～2030年)

Tuberculosis Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

全球結核診斷的市場規模，2022年～2030年的預測期間預計以4.5％的年複合成長率成長。罹患結核的多數患者，世間對結核和早期診斷相關的意識高漲，結核菌素反應檢驗和細胞激素檢驗等的檢驗方法的技術進步，成為市場促進因素。

本報告提供全球結核診斷市場相關調查分析，市場動態，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 結核診斷市場:競爭分析

  • 主要的結核診斷市場供應商的市場定位
  • 結核診斷市場供應商採用的策略
  • 主要的產業策略
  • 階層分析(2021年 vs. 2030年)

第4章 結核診斷市場:常量分析和市場動態

  • 簡介
  • 全球結核診斷的市場金額(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響的分析
  • See-Saw分析

第5章 結核診斷市場:各檢查(2020年～2030年)

  • 市場概要
  • 成長和收益的分析:(2021年 vs. 2030年)
  • 市場區隔
    • X光攝影法
    • 實驗室的方法
    • 核酸檢驗
    • 噬菌體化驗
    • 細胞激素檢驗
    • 藥物抗性的檢測
    • 結核菌素反應檢驗

第6章 北美的結核診斷市場(2020年～2030年)

  • 市場概要
  • 結核診斷市場:各檢查(2020年～2030年)
  • 結核診斷市場:各地區(2020年～2030年)
    • 北美

第7章 英國、歐洲聯盟的結核診斷市場(2020年～2030年)

  • 市場概要
  • 結核診斷市場:各檢查(2020年～2030年)
  • 結核診斷市場:各地區(2020年～2030年)
    • 英國、歐洲聯盟

第8章 亞太地區的結核診斷市場(2020年～2030年)

  • 市場概要
  • 結核診斷市場:各檢查(2020年～2030年)
  • 結核診斷市場:各地區(2020年～2030年)
    • 亞太地區

第9章 南美的結核診斷市場(2020年～2030年)

  • 市場概要
  • 結核診斷市場:各檢查(2020年～2030年)
  • 結核診斷市場:各地區(2020年～2030年)
    • 南美

第10章 中東、非洲的結核診斷市場(2020年～2030年)

  • 市場概要
  • 結核診斷市場:各檢查(2020年～2030年)
  • 結核診斷市場:各地區(2020年～2030年)
    • 中東、非洲

第11章 企業簡介

  • Abbott Laboratories
  • Alere, Inc.
  • Becton Dickinson and Company
  • bioMerieux SA
  • Cepheid Inc.
  • Epistem plc
  • F. Hoffman La Roche AG
  • Hain Lifescience GmbH
  • Hologic Corporation
  • Thermo Fisher Scientific, Inc.
  • QIAGEN
Product Code: 137575-08-22

This report on global tuberculosis diagnostics market studies various tuberculosis diagnostics test type. Healthcare regulatory agencies such as WHO, CDC are taking initiatives towards global awareness of tuberculosis and improvising the diagnostic methods. Large patient pool suffering with tuberculosis, rising public awareness regarding tuberculosis and early diagnosis and technological advancement in the testing methods such as Mantoux test, and Cytokine detection test are the driving factors for the tuberculosis diagnostics market.

The global tuberculosis diagnostics market is growing at a CAGR of 4.5% during the forecast period from 2022 to 2030. Tuberculosis accounts for a large share of the global infectious disease burden, resulting in about 9.6 million new cases and 1.5 million deaths per year. Tuberculosis is highly prevalent in under developed parts of the world affecting millions of lives, especially in Asia and Africa. Curently, tuberculosis has also developed into more diverse and potent forms that are referred as multi-drug resistant (MDR) or extensively drug resistant (XDR) tubercuolsis. These conditions are also spreading at a rapid rate and require extensive diagnostic and treatment measures to check its spread globally. According to World Health Organization (WHO) in 0.49 million new cases of MDR tuberculosis was recorded in 2016, and 47% of these cases were from China, India and Russia.

Continuous and effective control measures and programs carried out by WHO and other global health organizations such as Stop TB and DOTS (Directly Observed Treatment, Short-course) most developed nations have been able to minimize the spread of this disease. Various tuberculosis diagnostics tests are available in the global market for early and accurate diagnosis of the disease, thus ensuring proper treatment of the affected patient population. Some of the major commercially available tuberculosis diagnostic tests include nucleic acid tests, culture tests, tuberculin skin tests, chest X-ray, sputum smear microscopy, and drug susceptibility testing. The latest next-generation Xpert MTB/RIF Ultra diagnostic test by Cephied, Inc., has shown significant sensitivity in detection of Mycobacterium tuberculosis and is recommended by WHO.

The major players operating in the market include Alere, Inc., Abbott Laboratories, Thermo Fisher Scientific Corporation, Becton Dickinson and Company, BioMerieux Company and Cephied, Inc., among others.

Detection of drug resistance is projected to exhibit fastest growth rate

Tuberculosis is one of the leading cause of death worldwide, according to the World Health Organization in 2013 around 9 million new cases of tuberculosis were reported with approximately 1.5 million deaths. The tuberculosis diagnostic market segment is driven by factors such as increasing diagnosis rate in the high prevalence regions, advanced technologies such as radiographic methods and cytokine detection test, cost efficient diagnostic tests are in demand and launching of technologically advanced diagnostic kits.

In 2021 laboratory diagnostics held the largest market share in the test type segment chiefly due to factors such as rising prevalence of tuberculosis they are affordable and very easy to perform. The restraints of the laboratory diagnostic test are compromised accuracy and the long incubation period required for the interpretation of diagnosis. Nucleic acid test and Mantoux test will be the fastest growing market throughout the forecast period due to key market drivers such as advanced techniques, less incubation period required for interpretation of the diagnosis performed, and high accuracy. The major players involved the manufacturing of the diagnostic kits and equipment are Alere, Inc. Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, F.Hoffman La Roche AG, Qiagen, BioMerieux SA, Cephied, Inc., Epistem plc., Hain Lifescience GmbH and Hologic Corporation.

Asia Pacific is expected to witness the highest CAGR of 5.5%

North America will be the fastest-growing market for tuberculosis diagnostics throughout the forecast period 2022-2030. According to the Centers for Disease Control and Prevention, approximately 9,557 new cases of TB were reported in 2015, the market growth is mainly attributed to rising public awareness of tuberculosis leading to early diagnosis, evolved reimbursement scenario, and developed healthcare infrastructure. According to the World Health Organization (WHO) in 2015, 323,000 new TB cases were reported in Europe i.e. approximately 900 people suffered with TB each day. Europe is expected to be the second largest market due to rising prevalence of MDR-TB, government & non-government organizations grants to strengthen R&D facilities to launch novel tuberculosis diagnostics testing kits, and supportive regulatory approval for tuberculosis diagnostics market.

In base year 2021, Asia Pacific was observed as the leading market for tuberculosis diagnostics due to factors such as rising prevalence of tuberculosis, according to World Health Organization in South East Asia annually 2 million people are diagnosed with TB, competitive market due to manufactures involved in tuberculosis diagnostic kit production, increasing disposable income in these regions and government and non-government initiatives to mitigate tuberculosis as per TB programmes. However, factors such as developing health infrastructure, increasing awareness about tuberculosis diagnostics are going to fuel the rapid growth of tuberculosis diagnostics market in Latin America and Middle East and Africa region in the near future.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Tuberculosis Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Tuberculosis Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Test

Radiographic Methods

Laboratory Methods

Smear Microscopy

Culture Based Test

Nucleic Acid Testing

Phage Assay

Cytokine Detection Test

Detection of Drug Resistance

Mantoux Test

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Tuberculosis Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Tuberculosis Diagnostics market?

Which is the largest regional market for Tuberculosis Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Tuberculosis Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Tuberculosis Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Tuberculosis Diagnostics Market
  • 2.2. Global Tuberculosis Diagnostics Market, By Test, 2021 (US$ Million)
  • 2.3. Global Tuberculosis Diagnostics Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Tuberculosis Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Tuberculosis Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Tuberculosis Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Tuberculosis Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Tuberculosis Diagnostics Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Radiographic Methods
    • 5.3.2. Laboratory Methods
      • 5.3.2.1. Smear Microscopy
      • 5.3.2.2. Culture Based Test
    • 5.3.3. Nucleic Acid Testing
    • 5.3.4. Phage Assay
    • 5.3.5. Cytokine Detection Test
    • 5.3.6. Detection of Drug Resistance
    • 5.3.7. Mantoux Test

6. North America Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
  • 6.3.Tuberculosis Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)

7. UK and European Union Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
  • 7.3.Tuberculosis Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)

8. Asia Pacific Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
  • 8.3.Tuberculosis Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)

9. Latin America Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
  • 9.3.Tuberculosis Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)

10. Middle East and Africa Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
  • 10.3.Tuberculosis Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Alere, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Becton Dickinson and Company
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. bioMerieux SA
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Cepheid Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Epistem plc
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. F. Hoffman La Roche AG
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Hain Lifescience GmbH
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Hologic Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Thermo Fisher Scientific, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. QIAGEN
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 2 Global Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 3 North America Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 4 North America Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 5 U.S. Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 6 U.S. Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 7 Canada Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 8 Canada Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 13 UK Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 14 UK Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 15 Germany Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 16 Germany Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 17 Spain Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 18 Spain Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 19 Italy Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 20 Italy Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 21 France Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 22 France Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 25 Asia Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 26 Asia Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 27 China Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 28 China Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 29 Japan Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 30 Japan Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 31 India Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 32 India Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 33 Australia Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 34 Australia Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 35 South Korea Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 36 South Korea Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 37 Latin America Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 38 Latin America Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 39 Brazil Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 40 Brazil Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 41 Mexico Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 42 Mexico Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 47 GCC Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 48 GCC Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 49 Africa Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 50 Africa Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Tuberculosis Diagnostics Market By Test, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Tuberculosis Diagnostics Market By Laboratory Methods, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Tuberculosis Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Tuberculosis Diagnostics Market: Quality Assurance
  • FIG. 5 Global Tuberculosis Diagnostics Market, By Test, 2021
  • FIG. 6 Global Tuberculosis Diagnostics Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Tuberculosis Diagnostics Market, 2021
  • FIG. 8 Market Positioning of Key Tuberculosis Diagnostics Market Players, 2021
  • FIG. 9 Global Tuberculosis Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Tuberculosis Diagnostics Market, By Test, 2021 Vs 2030, %
  • FIG. 11 U.S. Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 18 France Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 20 China Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 22 India Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Tuberculosis Diagnostics Market (US$ Million), 2020 - 2030